\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ reveals\\ right\\-sided\\ motor\\ weakness\\.\ \(0\)\
\-\ referred\\ for\\ neurosurgery\\ consultation\\.\ \(0\)\
\-\ conventional\\ mr\\ imaging\\ demonstrates\\ a\\ large\\ \\,\\ intra\\-axial\\ left\\ temporal\\ mass\\ lesion\\.\\ the\\ lesion\\ is\\ infiltrative\\,\\ exerts\\ significant\\ mass\\ effect\\ on\\ the\\ adjacent\\ structures\\,\\ producing\\ mild\\ rightward\\ midline\\ shift\\,\\ and\\ is\\ surrounded\\ by\\ a\\ large\\ amount\\ of\\ edema\\.\\ the\\ mass\\ lesion\\ demonstrates\\ heterogeneously\\ high\\ signal\\ intensity\\ on\\ t2\\ and\\ flair\\ sequences\\ and\\ is\\ hypo\\-isointense\\ on\\ the\\ t1\\ weighted\\ images\\.\\ the\\ tumor\\ contains\\ scattered\\ t1\\ hyperintense\\ areas\\ compatible\\ with\\ subacute\\ hemorrhagic\\ elements\\.\\ following\\ gadolinium\\-based\\ contrast\\ administration\\,\\ the\\ mass\\ lesion\\ exhibits\\ intense\\,\\ irregular\\ ring\\ enhancement\\.\\ heterogeneous\\,\\ vivid\\ enhancement\\ is\\ noted\\ in\\ a\\ central\\ solid\\ component\\ of\\ the\\ mass\\.\\ extensive\\ nonenhancing\\ necrotic\\ areas\\ are\\ present\\ in\\ the\\ center\\ of\\ the\\ mass\\ lesion\\.\\ diffusion\\ weighted\\ imaging\\ \\(dwi\\)\\ reveals\\ no\\ evidence\\ of\\ restricted\\ diffusion\\.\\ dynamic\\ susceptibility\\ contrast\\ \\(dsc\\-perfusion\\)\\ mr\\ imaging\\ \\ demonstrates\\ elevated\\ blood\\ volume\\ \\(rcbv\\ values\\)\\ along\\ the\\ enhancing\\ tumor\\ margins\\.\\ the\\ constellation\\ of\\ mr\\ imaging\\ findings\\ is\\ compatible\\ with\\ the\\ presence\\ of\\ multiforme\\ glioblastoma\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ differential\\ diagnosis\\ includes\\:\ \(0\)\
\-\ metastasis\\,\\ anaplastic\\ astrocytoma\\,\\ primary\\ cns\\ lymphoma\\,\\ anaplastic\\ oligoastrocytoma\\,\\ anaplastic\\ oligodendroglioma\\,\\ abscess\\,\\ tumefactive\\ demyelination\\,\\ subacute\\ ischemia\\,\\ arteriovenous\\ malformation\ \(0\)\
\-\ a\\ 70\\ y\\.o\\.\\ man\\ presents\\ with\\ a\\ several\\ weeks\\ history\\ of\\ headache\\,\\ confusion\\,\\ and\\ right\\ sided\\ weakness\\.\ \(0\)\
\-\ although\\ there\\ is\\ no\\ histological\\ confirmation\\ in\\ this\\ case\\ \\,\\ conventional\\ mr\\ imaging\\ and\\ advanced\\ mri\\ techniques\\ are\\ in\\ keeping\\ with\\ a\\ high\\ grade\\ glioma\\ \\(glioblastoma\\,\\ who\\ gr4\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ anaplastic\\:\\ 0\\.06024102111359722\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.05266393163947597\ \(0\)\
\-\ mr\\:\\ 0\\.04052536525293185\ \(0\)\
\-\ imaging\\:\\ 0\\.0373521235905896\ \(0\)\
\-\ multiforme\\:\\ 0\\.03705500613624209\ \(0\)\
\-\ conventional\\:\\ 0\\.03615840679413714\ \(0\)\
\-\ compatible\\:\\ 0\\.03523264075928655\ \(0\)\
\-\ hypo\\-isointense\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ vivid\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ dsc\\-perfusion\\:\\ 0\\.03289372546256156\ \(0\)\
\-\ subacute\\:\\ 0\\.03272165391882973\ \(0\)\
\-\ lesion\\:\\ 0\\.03247304526120251\ \(0\)\
\-\ gadolinium\\-based\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ gr4\\:\\ 0\\.030307355385845346\ \(0\)\
\-\ diffusion\\:\\ 0\\.028545416695431057\ \(0\)\
\-\ weighted\\:\\ 0\\.027728746239867905\ \(0\)\
\-\ rcbv\\:\\ 0\\.027720985309129132\ \(0\)\
\-\ oligoastrocytoma\\:\\ 0\\.027720985309129132\ \(0\)\
\-\ mass\\:\\ 0\\.02660733597643801\ \(0\)\
\-\ exerts\\:\\ 0\\.025632866697429795\ \(0\)\
\-\ reveals\\:\\ 0\\.02494961007682853\ \(0\)\
\-\ susceptibility\\:\\ 0\\.024695126293396562\ \(0\)\
\-\ keeping\\:\\ 0\\.024695126293396562\ \(0\)\
\-\ weakness\\:\\ 0\\.02368366681364466\ \(0\)\
\-\ rightward\\:\\ 0\\.02304649662071358\ \(0\)\
\-\ intra\\-axial\\:\\ 0\\.0227890605330757\ \(0\)\
\-\ areas\\:\\ 0\\.021457814710791542\ \(0\)\
\-\ exhibits\\:\\ 0\\.021359984964955902\ \(0\)\
\-\ nonenhancing\\:\\ 0\\.021359984964955902\ \(0\)\
\-\ demyelination\\:\\ 0\\.02119412017924384\ \(0\)\
\-\ demonstrates\\:\\ 0\\.020895013451341635\ \(0\)\
\-\ dynamic\\:\\ 0\\.020595826708814064\ \(0\)\
\-\ constellation\\:\\ 0\\.020595826708814064\ \(0\)\
\-\ tumefactive\\:\\ 0\\.020595826708814064\ \(0\)\
\-\ t1\\:\\ 0\\.020212653255404806\ \(0\)\
\-\ histological\\:\\ 0\\.01984705545708962\ \(0\)\
\-\ \\,\\:\\ 0\\.019192131510553954\ \(0\)\
\-\ confusion\\:\\ 0\\.019129249887509556\ \(0\)\
\-\ confirmation\\:\\ 0\\.019129249887509556\ \(0\)\
\-\ techniques\\:\\ 0\\.019037113273366383\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.01877361488823969\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.018689760948493204\ \(0\)\
\-\ infiltrative\\:\\ 0\\.018296624696038627\ \(0\)\
\-\ producing\\:\\ 0\\.018296624696038627\ \(0\)\
\-\ surrounded\\:\\ 0\\.018222734295679745\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.017940989696768758\ \(0\)\
\-\ consultation\\:\\ 0\\.01780771326914906\ \(0\)\
\-\ elements\\:\\ 0\\.01749397029448286\ \(0\)\
\-\ high\\:\\ 0\\.017451836276692653\ \(0\)\
\-\ necrotic\\:\\ 0\\.017434267528264796\ \(0\)\
\-\ enhancement\\:\\ 0\\.017093199747186837\ \(0\)\
\-\ contains\\:\\ 0\\.01704113127581022\ \(0\)\
\-\ dwi\\:\\ 0\\.016936016063247922\ \(0\)\
\-\ intense\\:\\ 0\\.016884548443351147\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.016734272700299133\ \(0\)\
\-\ cns\\:\\ 0\\.016316668535358885\ \(0\)\
\-\ advanced\\:\\ 0\\.016316668535358885\ \(0\)\
\-\ values\\:\\ 0\\.01594113299140483\ \(0\)\
\-\ center\\:\\ 0\\.01563636421896353\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.01556390867472062\ \(0\)\
\-\ 70\\:\\ 0\\.015320851577067777\ \(0\)\
\-\ shift\\:\\ 0\\.015124419735704261\ \(0\)\
\-\ volume\\:\\ 0\\.01506117511513048\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.014877629427851482\ \(0\)\
\-\ tumor\\:\\ 0\\.014867405235901576\ \(0\)\
\-\ scattered\\:\\ 0\\.014847897451548584\ \(0\)\
\-\ ring\\:\\ 0\\.014818400513089205\ \(0\)\
\-\ ischemia\\:\\ 0\\.014818400513089205\ \(0\)\
\-\ restricted\\:\\ 0\\.014674315303657192\ \(0\)\
\-\ flair\\:\\ 0\\.014618203820953682\ \(0\)\
\-\ component\\:\\ 0\\.014562923650113605\ \(0\)\
\-\ margins\\:\\ 0\\.014481509294163456\ \(0\)\
\-\ glioma\\:\\ 0\\.014375648483979816\ \(0\)\
\-\ contrast\\:\\ 0\\.014274445423939592\ \(0\)\
\-\ large\\:\\ 0\\.013944346506202087\ \(0\)\
\-\ motor\\:\\ 0\\.013315277432111985\ \(0\)\
\-\ amount\\:\\ 0\\.013315277432111985\ \(0\)\
\-\ sequences\\:\\ 0\\.013315277432111985\ \(0\)\
\-\ hyperintense\\:\\ 0\\.0132375383018775\ \(0\)\
\-\ administration\\:\\ 0\\.0132375383018775\ \(0\)\
\-\ includes\\:\\ 0\\.012854031327756848\ \(0\)\
\-\ temporal\\:\\ 0\\.012768249543336331\ \(0\)\
\-\ extensive\\:\\ 0\\.012751327322569945\ \(0\)\
\-\ irregular\\:\\ 0\\.012717711389949177\ \(0\)\
\-\ solid\\:\\ 0\\.012717711389949177\ \(0\)\
\-\ malformation\\:\\ 0\\.012717711389949177\ \(0\)\
\-\ is\\:\\ 0\\.012588599516075947\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.012381903726392895\ \(0\)\
\-\ midline\\:\\ 0\\.012336306296039257\ \(0\)\
\-\ structures\\:\\ 0\\.012276363749383262\ \(0\)\
\-\ grade\\:\\ 0\\.01214491340653347\ \(0\)\
\-\ referred\\:\\ 0\\.012031833744237467\ \(0\)\
\-\ metastasis\\:\\ 0\\.011935624351865399\ \(0\)\
\-\ sided\\:\\ 0\\.011789278407263602\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.011724608794011214\ \(0\)\
\-\ presence\\:\\ 0\\.011573826934541526\ \(0\)\
\-\ intensity\\:\\ 0\\.011524890583504855\ \(0\)\
\-\ effect\\:\\ 0\\.011289396466676286\ \(0\)\
\-\ headache\\:\\ 0\\.01095143819987238\ \(0\)\
\-\ elevated\\:\\ 0\\.010818344631936802\ \(0\)\
\-\ \\(\\:\\ 0\\.010781518302147172\ \(0\)\
\-\ although\\:\\ 0\\.010768392837972401\ \(0\)\
\-\ \\)\\:\\ 0\\.010649816300198582\ \(0\)\
\-\ along\\:\\ 0\\.010537514465889986\ \(0\)\
\-\ central\\:\\ 0\\.010491161779328205\ \(0\)\
\-\ several\\:\\ 0\\.010250346401949207\ \(0\)\
\-\ differential\\:\\ 0\\.010122984437884066\ \(0\)\
\-\ adjacent\\:\\ 0\\.010081478522889056\ \(0\)\
\-\ abscess\\:\\ 0\\.010081478522889056\ \(0\)\
\-\ enhancing\\:\\ 0\\.009999826615241639\ \(0\)\
\-\ examination\\:\\ 0\\.009912026251770767\ \(0\)\
\-\ primary\\:\\ 0\\.009445463667521255\ \(0\)\
\-\ y\\.o\\:\\ 0\\.009202908330547389\ \(0\)\
\-\ lymphoma\\:\\ 0\\.009112681471602558\ \(0\)\
\-\ following\\:\\ 0\\.009049543869034135\ \(0\)\
\-\ weeks\\:\\ 0\\.009049543869034135\ \(0\)\
\-\ t2\\:\\ 0\\.0090245849580237\ \(0\)\
\-\ edema\\:\\ 0\\.009018371229221235\ \(0\)\
\-\ a\\:\\ 0\\.008879100040714953\ \(0\)\
\-\ blood\\:\\ 0\\.008703026389960072\ \(0\)\
\-\ are\\:\\ 0\\.008693088600967177\ \(0\)\
\-\ significant\\:\\ 0\\.008574056533784416\ \(0\)\
\-\ signal\\:\\ 0\\.008406993769674548\ \(0\)\
\-\ mild\\:\\ 0\\.008396468111683347\ \(0\)\
\-\ evidence\\:\\ 0\\.008359860385697304\ \(0\)\
\-\ who\\:\\ 0\\.008313314959483963\ \(0\)\
\-\ on\\:\\ 0\\.008103257601105538\ \(0\)\
\-\ physical\\:\\ 0\\.007822780856646411\ \(0\)\
\-\ noted\\:\\ 0\\.007557541747957439\ \(0\)\
\-\ man\\:\\ 0\\.007540790459291041\ \(0\)\
\-\ mri\\:\\ 0\\.007325656175054551\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007321713920822462\ \(0\)\
\-\ present\\:\\ 0\\.0072015252012376145\ \(0\)\
\-\ case\\:\\ 0\\.006975762809206234\ \(0\)\
\-\ findings\\:\\ 0\\.006786704984290894\ \(0\)\
\-\ presents\\:\\ 0\\.006513598117566887\ \(0\)\
\-\ no\\:\\ 0\\.0064212250052522535\ \(0\)\
\-\ in\\:\\ 0\\.0062895108976157455\ \(0\)\
\-\ the\\:\\ 0\\.006190266479266827\ \(0\)\
\-\ images\\:\\ 0\\.006116656313243859\ \(0\)\
\-\ by\\:\\ 0\\.005309219788227145\ \(0\)\
\-\ there\\:\\ 0\\.004745207300242495\ \(0\)\
\-\ history\\:\\ 0\\.004403785588459266\ \(0\)\
\-\ \\:\\:\\ 0\\.00421744334324875\ \(0\)\
\-\ this\\:\\ 0\\.0035863328855004965\ \(0\)\
\-\ left\\:\\ 0\\.0035675569748989354\ \(0\)\
\-\ right\\:\\ 0\\.0033642974220537934\ \(0\)\
\-\ and\\:\\ 0\\.0033583769726160157\ \(0\)\
\-\ of\\:\\ 0\\.0030430097223355184\ \(0\)\
\-\ for\\:\\ 0\\.002720552793442967\ \(0\)\
\-\ \\.\\:\\ 0\\.0019869143338066947\ \(0\)\
\-\ with\\:\\ 0\\.0017463309864162648\ \(0\)\
